‼️Just shared at #IDWeek2025, our findings are now published in @OFIDJournal comparing cephalexin to cefdinir for uUTI in females. Spoiler: cefdinir was the only independent risk factor associated with/failure. Poor urinary PK = ⬆️failure. Let’s stop Rx’ing cefdinir for UTI! 🛑💊
BREAKING: @US_FDA approves @BavarianNordic's Vimkunya vaccine for individuals 12+, offering up to 97.8% efficacy based on Phase 3 trial results. Milestone in combating #chikungunya, the mosquito-borne illness. #FDAapproval
Read here: https://t.co/oqsspMkiOj
The removal of #HIV- and #LGBTQ-related resources from the websites of the @CDCgov and other health agencies is deeply concerning.
Access to this information is crucial for ID and HIV health care professionals.
Our full statement: https://t.co/xcqdZ6515p
Although Dikembe is no longer with us, he still inspires us https://t.co/4HaZuvvXtx and this is STILL my favorite video!!
IT TAKES ALL of US #USAAW24#AntimicrobialResistance
AUC Vs Trough in Pediatrics 🔥
71% of patients with Cmin values of 5–10 mg/L had an AUC0–24 within the therapeutic range of 400–600 mg * h/L
23 patients (92%) with a SUPRAtherapeutic AUC0–24 had a Cmin value ≥15 mg/L.
~ 10% of patients experienced AKI
https://t.co/5lv2sMjRVl
Wow., it's published! @BradSpellberg et al @CMIJournal
🔥Choosing Patients Over Placebos: Oral Transitional Therapy vs. IV-Only Therapy for Bacteremia and Infective Endocarditis🔥 #IDTwitter
https://t.co/JSYPYnK64E
@ErinMcCreary giving us a unique argument for advocating IV to PO abx switch for serious infections ➡️ Saving massive amounts of nursing time! ⏰ (avg 22 min to administer IV vs. 80 seconds for PO) 🤯
@MAD_ID_ASP#MADID2023
Katie Olney, PharmD, BCIDP, has received a Society of Infectious Diseases Pharmacists (@SIDPharm) Early Career Award for her project "Pharmacokinetic/Pharmacodynamic Evaluation of Fixed-Dose Daptomycin."
Congratulations, R512! @UKPharmRes@ResearchKY@UK_HealthCare
Reminder❗️ PGY1 Acute and Ambulatory Care residency applications are due TODAY! Good luck to all candidates💙 #pharmacy#pharmacyresidency#pharmres https://t.co/SBOOEqiNtO
🗣️APPLICATION DEADLINES🗣️
We look forward to learning more about all of the fantastic applicants this year as our program deadlines approach!! Keep reaching out and asking great questions. Link in bio for program info 💙🤍
CONGRATULATIONS🎉 to our current PGY1's on successfully early committing for PGY2 specialty training!
If you want to join our next class of PGY2 residents, don't forget to sign up for our upcoming information sessions!
https://t.co/5oCnlGMi0k
🥳 The @UKPharmRes PGY2 Critical Care Program has early committed all positions for the 2023-24 year.
👏 Congratulations to Taylor Carr, Lauren Hochstetler, and Kendall Huntt!
#PharmICU#PharmRes@CARRvedilol@KendallHuntt
HEY, CURRENT PGY1'S! 🗣 We're recruiting for PGY2's in Cardiology 🫀, Ambulatory Care🩹, Infectious Diseases🦠, Emergency Medicine🚨, and Medication Use Safety & Policy⛑️. Join our information sessions on 11/15 and 11/21! 💙💊🤍 RSVP below 👇
https://t.co/hMTvTyPM0a
If your friend walked across a tiny rope 35 feet in the air, would you do it too?🤔 Each year residents attend an event to support leadership, team building, and decision making. This year they attended a ropes course! Safe to say everyone left ready to explore new heights!🌳